Evaluation of a Fixed‐Dose Insulin Protocol for Hypertriglyceridemia‐Induced Acute Pancreatitis: A Retrospective Cohort Study
Clinical Endocrinology · 2026
DOI: 10.1111/cen.70071 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Neden Yacine und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Intermountain Medical Center, Murray, Utah, USA. Hauptthemen laut MEDLINE: Hypertriglyceridemia, Pancreatitis, Insulin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objective
Hypertriglyceridemia‐induced acute pancreatitis (HTG‐AP) is a severe and increasingly common form of pancreatitis requiring prompt triglyceride‐lowering therapy. This study aimed to evaluate the safety and effectiveness of a standardized fixed‐dose insulin drip protocol option implemented across a healthcare system.
Design
Multicenter retrospective cohort study. Patients A total of 466 adult patients admitted with HTG‐AP between 15 July 2017, and 10 October 2024. Patients were divided into pre‐protocol ( n = 242) and post‐protocol ( n = 224) groups based on implementation of the fixed‐dose insulin protocol on 10 June 2021.
Measurements
The primary outcome was intensive care unit (ICU) length of stay. Secondary outcomes included hospital length of stay and time to achieve triglyceride levels < 1000 mg/dL (11.3 mmol/L). Safety outcomes included incidence of hypoglycemia and hypokalemia.
Results
Baseline demographics were generally similar between groups, with higher rates of a history of diabetes and hyperlipidemia in the post‐protocol group. No statistically significant differences were observed in ICU length of stay, hospital length of stay, or time to triglyceride reduction. Mild hypoglycemia was more common post‐protocol (36.6% vs. 25.2%, p = 0.008), while rates of severe hypoglycemia and hypokalemia were low and comparable between groups.
Conclusions
The fixed‐dose insulin protocol demonstrated similar clinical outcomes to historical care with an acceptable safety profile. This protocol offers a reproducible and standardized approach to managing HTG‐AP in diverse inpatient settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Intermountain Medical Center, Murray, Utah, USA.
- Department of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, Utah, USA.
- Division of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, Utah, USA.
ORCID-Profile: Neden Yacine, Daniel B Knox
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Yacine, N., Chauv, S., Peng, M. R., Knox, D. B., Lanspa, M. J., & Grissom, C. K. (2026). Evaluation of a Fixed‐Dose Insulin Protocol for Hypertriglyceridemia‐Induced Acute Pancreatitis: A Retrospective Cohort Study. Clinical Endocrinology. https://doi.org/10.1111/cen.70071
Vancouver
Yacine N, Chauv S, Peng MR, Knox DB, Lanspa MJ, Grissom CK. Evaluation of a Fixed‐Dose Insulin Protocol for Hypertriglyceridemia‐Induced Acute Pancreatitis: A Retrospective Cohort Study. Clinical Endocrinology. 2026. doi:10.1111/cen.70071
BibTeX
@article{Yacine2026,
author = {Yacine, Neden and Chauv, Stephanie and Peng, Melissa R and Knox, Daniel B and Lanspa, Michael J and Grissom, Colin K},
title = {Evaluation of a Fixed‐Dose Insulin Protocol for Hypertriglyceridemia‐Induced Acute Pancreatitis: A Retrospective Cohort Study},
journal = {Clinical Endocrinology},
year = {2026},
doi = {10.1111/cen.70071}
}
EUVIMED